FDA experts among group opposing US booster shot plan
The average person doesn’t need a COVID-19 booster yet, an international group of scientists — including two top U.S. regulators — wrote Monday in a scientific journal.
COLUMBIA BASIN HERALD | UPDATED 3 YEARS, 2 MONTHS AGO
FDA experts among group opposing US booster shot plan
The average person doesn’t need a COVID-19 booster yet, an international group of scientists — including two top U.S. regulators — wrote Monday in a scientific journal.
COLUMBIA BASIN HERALD | UPDATED 3 YEARS, 2 MONTHS AGO
FDA experts among group opposing US booster shot plan
The average person doesn’t need a COVID-19 booster yet, an international group of scientists — including two top U.S. regulators — wrote Monday in a scientific journal.
COLUMBIA BASIN HERALD | UPDATED 3 YEARS, 2 MONTHS AGO
FDA delays decision on e-cigarettes from vaping giant Juul
WASHINGTON (AP) — Federal health officials on Thursday delayed a high-stakes decision on whether to permit bestselling vaping brand Juul to stay on the market, while banning the sale of thousands of other electronic cigarettes.
COLUMBIA BASIN HERALD | UPDATED 3 YEARS, 2 MONTHS AGO
FDA delays decision on e-cigarettes from vaping giant Juul
WASHINGTON (AP) — Federal health officials on Thursday delayed a high-stakes decision on whether to permit bestselling vaping brand Juul to stay on the market, while banning the sale of thousands of other electronic cigarettes.
COLUMBIA BASIN HERALD | UPDATED 3 YEARS, 2 MONTHS AGO
FDA delays decision on e-cigarettes from vaping giant Juul
WASHINGTON (AP) — Federal health officials on Thursday delayed a high-stakes decision on whether to permit bestselling vaping brand Juul to stay on the market, while banning the sale of thousands of other electronic cigarettes.
COLUMBIA BASIN HERALD | UPDATED 3 YEARS, 2 MONTHS AGO
COVID-19 surge in the US: The summer of hope ends in gloom
WASHINGTON (AP) — The summer that was supposed to mark America’s independence from COVID-19 is instead drawing to a close with the U.S. more firmly under the tyranny of the virus, with deaths per day back up to where they were in March.
COLUMBIA BASIN HERALD | UPDATED 3 YEARS, 2 MONTHS AGO
FDA delays decision on e-cigarettes from vaping giant Juul
WASHINGTON (AP) — Federal health officials on Thursday delayed a high-stakes decision on whether to permit bestselling vaping brand Juul to stay on the market, while banning the sale of thousands of other electronic cigarettes.
COLUMBIA BASIN HERALD | UPDATED 3 YEARS, 2 MONTHS AGO
COVID-19 surge in the US: The summer of hope ends in gloom
WASHINGTON (AP) — The summer that was supposed to mark America’s independence from COVID-19 is instead drawing to a close with the U.S. more firmly under the tyranny of the virus, with deaths per day back up to where they were in March.
COLUMBIA BASIN HERALD | UPDATED 3 YEARS, 2 MONTHS AGO
COVID-19 surge in the US: The summer of hope ends in gloom
WASHINGTON (AP) — The summer that was supposed to mark America’s independence from COVID-19 is instead drawing to a close with the U.S. more firmly under the tyranny of the virus, with deaths per day back up to where they were in March.
COLUMBIA BASIN HERALD | UPDATED 3 YEARS, 2 MONTHS AGO
What does full approval of Pfizer’s COVID-19 vaccine mean?
What does full approval of Pfizer’s COVID-19 vaccine mean?
COLUMBIA BASIN HERALD | UPDATED 3 YEARS, 2 MONTHS AGO
What does full approval of Pfizer’s COVID-19 vaccine mean?
What does full approval of Pfizer’s COVID-19 vaccine mean?
COLUMBIA BASIN HERALD | UPDATED 3 YEARS, 2 MONTHS AGO
US regulators give full approval to Pfizer COVID-19 vaccine
WASHINGTON (AP) — The U.S. gave full approval to Pfizer's COVID-19 vaccine Monday, potentially boosting public confidence in the shots and instantly opening the way for more universities, companies and local governments to make vaccinations mandatory.
COLUMBIA BASIN HERALD | UPDATED 3 YEARS, 2 MONTHS AGO
What does full approval of Pfizer’s COVID-19 vaccine mean?
What does full approval of Pfizer’s COVID-19 vaccine mean?
COLUMBIA BASIN HERALD | UPDATED 3 YEARS, 2 MONTHS AGO
US regulators give full approval to Pfizer COVID-19 vaccine
WASHINGTON (AP) — The U.S. gave full approval to Pfizer's COVID-19 vaccine Monday, potentially boosting public confidence in the shots and instantly opening the way for more universities, companies and local governments to make vaccinations mandatory.
COLUMBIA BASIN HERALD | UPDATED 3 YEARS, 2 MONTHS AGO
What does full approval of Pfizer’s COVID-19 vaccine mean?
What does full approval of Pfizer’s COVID-19 vaccine mean?
COLUMBIA BASIN HERALD | UPDATED 3 YEARS, 2 MONTHS AGO
US regulators give full approval to Pfizer COVID-19 vaccine
WASHINGTON (AP) — The U.S. gave full approval to Pfizer's COVID-19 vaccine Monday, potentially boosting public confidence in the shots and instantly opening the way for more universities, companies and local governments to make vaccinations mandatory.
COLUMBIA BASIN HERALD | UPDATED 3 YEARS, 2 MONTHS AGO
US health officials call for booster shots against COVID-19
WASHINGTON (AP) — U.S. health officials Wednesday announced plans to dispense COVID-19 booster shots to all Americans to shore up their protection amid the surging delta variant and signs that the vaccines' effectiveness is slipping.
COLUMBIA BASIN HERALD | UPDATED 3 YEARS, 2 MONTHS AGO
More protection: US likely to authorize COVID booster shots
WASHINGTON (AP) — After struggling for months to persuade Americans to get the COVID-19 vaccine, U.S. health officials could soon face a fresh challenge: talking vaccinated people into getting booster shots to gain longer-lasting protection as the delta variant sends infections soaring again.
COLUMBIA BASIN HERALD | UPDATED 3 YEARS, 2 MONTHS AGO
US health officials call for booster shots against COVID-19
WASHINGTON (AP) — U.S. health officials Wednesday announced plans to dispense COVID-19 booster shots to all Americans to shore up their protection amid the surging delta variant and signs that the vaccines' effectiveness is slipping.
COLUMBIA BASIN HERALD | UPDATED 3 YEARS, 3 MONTHS AGO
More protection: US likely to authorize COVID booster shots
WASHINGTON (AP) — After struggling for months to persuade Americans to get the COVID-19 vaccine, U.S. health officials could soon face a fresh challenge: talking vaccinated people into getting booster shots to gain longer-lasting protection as the delta variant sends infections soaring again.
COLUMBIA BASIN HERALD | UPDATED 3 YEARS, 3 MONTHS AGO
US health officials call for booster shots against COVID-19
WASHINGTON (AP) — U.S. health officials Wednesday announced plans to dispense COVID-19 booster shots to all Americans to shore up their protection amid the surging delta variant and signs that the vaccines' effectiveness is slipping.
COLUMBIA BASIN HERALD | UPDATED 3 YEARS, 3 MONTHS AGO
More protection: US likely to authorize COVID booster shots
WASHINGTON (AP) — After struggling for months to persuade Americans to get the COVID-19 vaccine, U.S. health officials could soon face a fresh challenge: talking vaccinated people into getting booster shots to gain longer-lasting protection as the delta variant sends infections soaring again.
COLUMBIA BASIN HERALD | UPDATED 3 YEARS, 3 MONTHS AGO
More protection: US likely to authorize COVID booster shots
WASHINGTON (AP) — After struggling for months to persuade Americans to get the COVID-19 vaccine, U.S. health officials could soon face a fresh challenge: talking vaccinated people into getting booster shots to gain longer-lasting protection as the delta variant sends infections soaring again.
COLUMBIA BASIN HERALD | UPDATED 3 YEARS, 3 MONTHS AGO
Extra COVID vaccine OK'd for those with weak immune systems
WASHINGTON (AP) — U.S. regulators say transplant recipients and others with severely weakened immune systems can get an extra dose of the Pfizer or Moderna COVID-19 vaccines to better protect them as the delta variant continues to surge.
COLUMBIA BASIN HERALD | UPDATED 3 YEARS, 3 MONTHS AGO
Extra COVID vaccine OK'd for those with weak immune systems
WASHINGTON (AP) — U.S. regulators say transplant recipients and others with severely weakened immune systems can get an extra dose of the Pfizer or Moderna COVID-19 vaccines to better protect them as the delta variant continues to surge.
COLUMBIA BASIN HERALD | UPDATED 3 YEARS, 3 MONTHS AGO
Extra COVID vaccine OK'd for those with weak immune systems
WASHINGTON (AP) — U.S. regulators say transplant recipients and others with severely weakened immune systems can get an extra dose of the Pfizer or Moderna COVID-19 vaccines to better protect them as the delta variant continues to surge.
COLUMBIA BASIN HERALD | UPDATED 3 YEARS, 3 MONTHS AGO
Extra COVID vaccine OK'd for those with weak immune systems
WASHINGTON (AP) — U.S. regulators say transplant recipients and others with severely weakened immune systems can get an extra dose of the Pfizer or Moderna COVID-19 vaccines to better protect them as the delta variant continues to surge.
COLUMBIA BASIN HERALD | UPDATED 3 YEARS, 3 MONTHS AGO
Moderna expanding kids vaccine study to better assess safety
WASHINGTON (AP) — Moderna said Monday it plans to expand the size of its COVID-19 vaccine study in younger children to better detect rare side effects, such as a type of heart inflammation recently flagged by U.S. health authorities.
COLUMBIA BASIN HERALD | UPDATED 3 YEARS, 3 MONTHS AGO
Moderna expanding kids vaccine study to better assess safety
WASHINGTON (AP) — Moderna said Monday it plans to expand the size of its COVID-19 vaccine study in younger children to better detect rare side effects, such as a type of heart inflammation recently flagged by U.S. health authorities.
COLUMBIA BASIN HERALD | UPDATED 3 YEARS, 3 MONTHS AGO
Moderna expanding kids vaccine study to better assess safety
WASHINGTON (AP) — Moderna said Monday it plans to expand the size of its COVID-19 vaccine study in younger children to better detect rare side effects, such as a type of heart inflammation recently flagged by U.S. health authorities.
COLUMBIA BASIN HERALD | UPDATED 3 YEARS, 3 MONTHS AGO
Moderna expanding kids vaccine study to better assess safety
WASHINGTON (AP) — Moderna said Monday it plans to expand the size of its COVID-19 vaccine study in younger children to better detect rare side effects, such as a type of heart inflammation recently flagged by U.S. health authorities.
COLUMBIA BASIN HERALD | UPDATED 3 YEARS, 3 MONTHS AGO
FDA head calls for inquiry into Alzheimer's drug review
WASHINGTON (AP) — The acting head of the Food and Drug Administration on Friday called for a government investigation into highly unusual contacts between her agency's drug reviewers and the maker of a controversial new Alzheimer's drug.
COLUMBIA BASIN HERALD | UPDATED 3 YEARS, 4 MONTHS AGO
FDA head calls for inquiry into Alzheimer's drug review
WASHINGTON (AP) — The acting head of the Food and Drug Administration on Friday called for a government investigation into highly unusual contacts between her agency's drug reviewers and the maker of a controversial new Alzheimer's drug.
COLUMBIA BASIN HERALD | UPDATED 3 YEARS, 4 MONTHS AGO
FDA head calls for inquiry into Alzheimer's drug review
WASHINGTON (AP) — The acting head of the Food and Drug Administration on Friday called for a government investigation into highly unusual contacts between her agency's drug reviewers and the maker of a controversial new Alzheimer's drug.
COLUMBIA BASIN HERALD | UPDATED 3 YEARS, 4 MONTHS AGO
FDA head calls for inquiry into Alzheimer's drug review
WASHINGTON (AP) — The acting head of the Food and Drug Administration on Friday called for a government investigation into highly unusual contacts between her agency's drug reviewers and the maker of a controversial new Alzheimer's drug.
COLUMBIA BASIN HERALD | UPDATED 3 YEARS, 4 MONTHS AGO
FDA head calls for probe into Alzheimer's drug review
WASHINGTON (AP) — The acting head of the Food and Drug Administration on Friday called for a government investigation into highly unusual contacts between some of her agency's drug reviewers and the maker of a controversial new Alzheimer's drug.
COLUMBIA BASIN HERALD | UPDATED 3 YEARS, 4 MONTHS AGO
Does new Alzheimer's drug work? Answers may miss 2030 target
WASHINGTON (AP) — When a controversial Alzheimer’s drug won U.S. approval, surprise over the decision quickly turned to shock at how long it might take to find out if it really works — nine years.
COLUMBIA BASIN HERALD | UPDATED 3 YEARS, 4 MONTHS AGO
Does new Alzheimer's drug work? Answers may miss 2030 target
WASHINGTON (AP) — When a controversial Alzheimer’s drug won U.S. approval, surprise over the decision quickly turned to shock at how long it might take to find out if it really works — nine years.
COLUMBIA BASIN HERALD | UPDATED 3 YEARS, 4 MONTHS AGO
Does new Alzheimer's drug work? Answers may miss 2030 target
WASHINGTON (AP) — When a controversial Alzheimer’s drug won U.S. approval, surprise over the decision quickly turned to shock at how long it might take to find out if it really works — nine years.
COLUMBIA BASIN HERALD | UPDATED 3 YEARS, 4 MONTHS AGO
Does new Alzheimer's drug work? Answers may miss 2030 target
WASHINGTON (AP) — When a controversial Alzheimer’s drug won U.S. approval, surprise over the decision quickly turned to shock at how long it might take to find out if it really works — nine years.
COLUMBIA BASIN HERALD | UPDATED 3 YEARS, 4 MONTHS AGO
US to spend $3.2B on treatments for COVID-19, other viruses
WASHINGTON (AP) — The United States is devoting $3.2 billion to speed development of antiviral pills to treat COVID-19 and other dangerous viruses that could turn into pandemics.
COLUMBIA BASIN HERALD | UPDATED 3 YEARS, 5 MONTHS AGO
US to spend $3.2B on treatments for COVID-19, other viruses
WASHINGTON (AP) — The United States is devoting $3.2 billion to speed development of antiviral pills to treat COVID-19 and other dangerous viruses that could turn into pandemics.
COLUMBIA BASIN HERALD | UPDATED 3 YEARS, 5 MONTHS AGO
US to spend $3.2B on treatments for COVID-19, other viruses
WASHINGTON (AP) — The United States is devoting $3.2 billion to speed development of antiviral pills to treat COVID-19 and other dangerous viruses that could turn into pandemics.
COLUMBIA BASIN HERALD | UPDATED 3 YEARS, 5 MONTHS AGO
US to spend $3.2B on treatments for COVID-19, other viruses
WASHINGTON (AP) — The United States is devoting $3.2 billion to speed development of antiviral pills to treat COVID-19 and other dangerous viruses that could turn into pandemics.
COLUMBIA BASIN HERALD | UPDATED 3 YEARS, 5 MONTHS AGO
Fauci: US to spend $3.2B for antiviral pills for COVID-19
WASHINGTON (AP) — The United States is devoting $3.2 billion to advance development of antiviral pills for COVID-19 and other dangerous viruses that could turn into pandemics.
COLUMBIA BASIN HERALD | UPDATED 3 YEARS, 5 MONTHS AGO
Medicare copays for new Alzheimer's drug could reach $11,500
WASHINGTON (AP) — A new $56,000-a-year Alzheimer’s drug would raise Medicare premiums broadly, and some patients who are prescribed the medication could face copayments of about $11,500 annually, according to a research report published Thursday.
COLUMBIA BASIN HERALD | UPDATED 3 YEARS, 5 MONTHS AGO
US extends expiration dates for J&J COVID vaccine by 6 weeks
WASHINGTON (AP) — Johnson & Johnson said Thursday that U.S. regulators extended the expiration date on millions of doses of its COVID-19 vaccine by six weeks.
COLUMBIA BASIN HERALD | UPDATED 3 YEARS, 5 MONTHS AGO
Medicare copays for new Alzheimer's drug could reach $11,500
WASHINGTON (AP) — A new $56,000-a-year Alzheimer’s drug would raise Medicare premiums broadly, and some patients who are prescribed the medication could face copayments of about $11,500 annually, according to a research report published Thursday.
COLUMBIA BASIN HERALD | UPDATED 3 YEARS, 5 MONTHS AGO
US extends expiration dates for J&J COVID vaccine by 6 weeks
WASHINGTON (AP) — Johnson & Johnson said Thursday that U.S. regulators extended the expiration date on millions of doses of its COVID-19 vaccine by six weeks.
COLUMBIA BASIN HERALD | UPDATED 3 YEARS, 5 MONTHS AGO
Medicare copays for new Alzheimer's drug could reach $11,500
WASHINGTON (AP) — A new $56,000-a-year Alzheimer’s drug would raise Medicare premiums broadly, and some patients who are prescribed the medication could face copayments of about $11,500 annually, according to a research report published Thursday.
COLUMBIA BASIN HERALD | UPDATED 3 YEARS, 5 MONTHS AGO
Medicare copays for new Alzheimer's drug could reach $11,500
WASHINGTON (AP) — A new $56,000-a-year Alzheimer’s drug would raise Medicare premiums broadly, and some patients who are prescribed the medication could face copayments of about $11,500 annually, according to a research report published Thursday.
COLUMBIA BASIN HERALD | UPDATED 3 YEARS, 5 MONTHS AGO
US extends expiration dates for J&J COVID vaccine by 6 weeks
WASHINGTON (AP) — Johnson & Johnson said Thursday that U.S. regulators extended the expiration date on millions of doses of its COVID-19 vaccine by six weeks.
COLUMBIA BASIN HERALD | UPDATED 3 YEARS, 5 MONTHS AGO
US officials extend expiration dates on J&J vaccine doses
WASHINGTON (AP) — Johnson & Johnson said Thursday that U.S. regulators extended the expiration date on millions of doses of its COVID-19 vaccine by an extra six weeks.
COLUMBIA BASIN HERALD | UPDATED 3 YEARS, 5 MONTHS AGO
FDA approves much-debated Alzheimer’s drug panned by experts
WASHINGTON (AP) — Government health officials on Monday approved the first new drug for Alzheimer’s disease in nearly 20 years, disregarding warnings from independent advisers that the much-debated treatment hasn’t been shown to help slow the brain-destroying disease.
COLUMBIA BASIN HERALD | UPDATED 3 YEARS, 5 MONTHS AGO
FDA approves much-debated Alzheimer’s drug panned by experts
WASHINGTON (AP) — Government health officials on Monday approved the first new drug for Alzheimer’s disease in nearly 20 years, disregarding warnings from independent advisers that the much-debated treatment hasn’t been shown to help slow the brain-destroying disease.
COLUMBIA BASIN HERALD | UPDATED 3 YEARS, 5 MONTHS AGO
FDA approves much-debated Alzheimer’s drug panned by experts
WASHINGTON (AP) — Government health officials on Monday approved the first new drug for Alzheimer’s disease in nearly 20 years, disregarding warnings from independent advisers that the much-debated treatment hasn’t been shown to help slow the brain-destroying disease.
COLUMBIA BASIN HERALD | UPDATED 3 YEARS, 5 MONTHS AGO
US vows again to ban menthol flavor in cigarettes, cigars
WASHINGTON (AP) — U.S. health regulators pledged again Thursday to try to ban menthol cigarettes, this time under pressure from African American groups to remove the mint flavor popular among Black smokers.
COLUMBIA BASIN HERALD | UPDATED 3 YEARS, 6 MONTHS AGO
US vows again to ban menthol flavor in cigarettes, cigars
WASHINGTON (AP) — U.S. health regulators pledged again Thursday to try to ban menthol cigarettes, this time under pressure from African American groups to remove the mint flavor popular among Black smokers.
COLUMBIA BASIN HERALD | UPDATED 3 YEARS, 6 MONTHS AGO
US vows again to ban menthol flavor in cigarettes, cigars
WASHINGTON (AP) — U.S. health regulators pledged again Thursday to try to ban menthol cigarettes, this time under pressure from African American groups to remove the mint flavor popular among Black smokers.
COLUMBIA BASIN HERALD | UPDATED 3 YEARS, 6 MONTHS AGO
US vows again to ban menthol flavor in cigarettes, cigars
WASHINGTON (AP) — U.S. health regulators pledged again Thursday to try to ban menthol cigarettes, this time under pressure from African American groups to remove the mint flavor popular among Black smokers.
COLUMBIA BASIN HERALD | UPDATED 3 YEARS, 6 MONTHS AGO
FDA revives federal effort to ban menthol cigarettes
WASHINGTON (AP) — U.S. health regulators pledged again Thursday to try to ban menthol cigarettes, this time under pressure from African American groups to remove the mint flavor popular among Black smokers.
COLUMBIA BASIN HERALD | UPDATED 3 YEARS, 6 MONTHS AGO
FDA to scrutinize unproven cancer drugs after 10-year gap
WASHINGTON (AP) — Each year the U.S. approves dozens of new uses for cancer drugs based on early signs that they can shrink or slow the spread of tumors.
COLUMBIA BASIN HERALD | UPDATED 3 YEARS, 6 MONTHS AGO
FDA to scrutinize unproven cancer drugs after 10-year gap
WASHINGTON (AP) — Each year the U.S. approves dozens of new uses for cancer drugs based on early signs that they can shrink or slow the spread of tumors.
COLUMBIA BASIN HERALD | UPDATED 3 YEARS, 6 MONTHS AGO
FDA to scrutinize unproven cancer drugs after 10-year gap
WASHINGTON (AP) — Each year the U.S. approves dozens of new uses for cancer drugs based on early signs that they can shrink or slow the spread of tumors.
COLUMBIA BASIN HERALD | UPDATED 3 YEARS, 6 MONTHS AGO
FDA to scrutinize unproven cancer drugs after 10-year gap
WASHINGTON (AP) — Each year the U.S. approves dozens of new uses for cancer drugs based on early signs that they can shrink or slow the spread of tumors.
COLUMBIA BASIN HERALD | UPDATED 3 YEARS, 6 MONTHS AGO
US agency says women can get abortion pill via mail
WASHINGTON (AP) — Women seeking an abortion pill will not be required to visit a doctor's office or clinic during the COVID-19 pandemic, U.S. health officials said Tuesday in the latest reversal in an ongoing legal battle over the medication.
COLUMBIA BASIN HERALD | UPDATED 3 YEARS, 7 MONTHS AGO
US recommends 'pause' for J&J shots in blow to vaccine drive
WASHINGTON (AP) — The U.S. on Tuesday recommended a “pause” in use of the single-dose Johnson & Johnson COVID-19 vaccine to investigate reports of rare but potentially dangerous blood clots, setting off a chain reaction worldwide and dealing a setback to the global vaccination campaign.
COLUMBIA BASIN HERALD | UPDATED 3 YEARS, 7 MONTHS AGO
US agency says women can get abortion pill via mail
WASHINGTON (AP) — Women seeking an abortion pill will not be required to visit a doctor's office or clinic during the COVID-19 pandemic, U.S. health officials said Tuesday in the latest reversal in an ongoing legal battle over the medication.
COLUMBIA BASIN HERALD | UPDATED 3 YEARS, 7 MONTHS AGO
US recommends 'pause' for J&J shots in blow to vaccine drive
WASHINGTON (AP) — The U.S. on Tuesday recommended a “pause” in use of the single-dose Johnson & Johnson COVID-19 vaccine to investigate reports of rare but potentially dangerous blood clots, setting off a chain reaction worldwide and dealing a setback to the global vaccination campaign.
COLUMBIA BASIN HERALD | UPDATED 3 YEARS, 7 MONTHS AGO
US agency says women can get abortion pill via mail
WASHINGTON (AP) — Women seeking an abortion pill will not be required to visit a doctor's office or clinic during the COVID-19 pandemic, U.S. health officials said Tuesday in the latest reversal in an ongoing legal battle over the medication.
COLUMBIA BASIN HERALD | UPDATED 3 YEARS, 7 MONTHS AGO
US recommends 'pause' for J&J shots in blow to vaccine drive
WASHINGTON (AP) — The U.S. on Tuesday recommended a “pause” in use of the single-dose Johnson & Johnson COVID-19 vaccine to investigate reports of rare but potentially dangerous blood clots, setting off a chain reaction worldwide and dealing a setback to the global vaccination campaign.
COLUMBIA BASIN HERALD | UPDATED 3 YEARS, 7 MONTHS AGO
US recommends 'pause' for J&J vaccine over clot reports
WASHINGTON (AP) — The U.S. on Tuesday recommended a “pause” in using the single-dose Johnson & Johnson COVID-19 vaccine to investigate reports of rare but potentially dangerous blood clots, a development that could jeopardize the rollout of vaccines around the world.
COLUMBIA BASIN HERALD | UPDATED 3 YEARS, 7 MONTHS AGO
J&J’s 1-dose shot cleared, giving US 3rd COVID-19 vaccine
WASHINGTON (AP) — The U.S. is getting a third vaccine to prevent COVID-19, as the Food and Drug Administration on Saturday cleared a Johnson & Johnson shot that works with just one dose instead of two.
COLUMBIA BASIN HERALD | UPDATED 3 YEARS, 8 MONTHS AGO
J&J’s 1-dose shot cleared, giving US 3rd COVID-19 vaccine
WASHINGTON (AP) — The U.S. is getting a third vaccine to prevent COVID-19, as the Food and Drug Administration on Saturday cleared a Johnson & Johnson shot that works with just one dose instead of two.
COLUMBIA BASIN HERALD | UPDATED 3 YEARS, 8 MONTHS AGO
J&J’s 1-dose shot cleared, giving US 3rd COVID-19 vaccine
WASHINGTON (AP) — The U.S. is getting a third vaccine to prevent COVID-19, as the Food and Drug Administration on Saturday cleared a Johnson & Johnson shot that works with just one dose instead of two.
COLUMBIA BASIN HERALD | UPDATED 3 YEARS, 8 MONTHS AGO
J&J’s 1-dose shot cleared, giving US 3rd COVID-19 vaccine
WASHINGTON (AP) — The U.S. is getting a third vaccine to prevent COVID-19, as the Food and Drug Administration on Saturday cleared a Johnson & Johnson shot that works with just one dose instead of two.
COLUMBIA BASIN HERALD | UPDATED 3 YEARS, 8 MONTHS AGO
Biden taps former FDA chief Kessler to lead vaccine science
WASHINGTON (AP) — President-elect Joe Biden has picked a former Food and Drug commissioner to lead vaccine science in his drive to put 100 million shots into the arms of Americans in his administration's first 100 days and stem the COVID-19 pandemic.
COLUMBIA BASIN HERALD | UPDATED 3 YEARS, 10 MONTHS AGO
Biden taps former FDA chief Kessler to lead vaccine science
WASHINGTON (AP) — President-elect Joe Biden has picked a former Food and Drug commissioner to lead vaccine science in his drive to put 100 million shots into the arms of Americans in his administration's first 100 days and stem the COVID-19 pandemic.
COLUMBIA BASIN HERALD | UPDATED 3 YEARS, 10 MONTHS AGO
Biden taps former FDA chief Kessler to lead vaccine science
WASHINGTON (AP) — President-elect Joe Biden has picked a former Food and Drug commissioner to lead vaccine science in his drive to put 100 million shots into the arms of Americans in his administration's first 100 days and stem the COVID-19 pandemic.
COLUMBIA BASIN HERALD | UPDATED 3 YEARS, 10 MONTHS AGO
Congress, LA take divergent paths after COVID test warning
LOS ANGELES (AP) — Los Angeles will continue using a coronavirus test that federal regulators warned may produce false results while Congress, which has used the same test, is seeking an alternative.
COLUMBIA BASIN HERALD | UPDATED 3 YEARS, 10 MONTHS AGO
Congress, LA take divergent paths after COVID test warning
LOS ANGELES (AP) — Los Angeles will continue using a coronavirus test that federal regulators warned may produce false results while Congress, which has used the same test, is seeking an alternative.
COLUMBIA BASIN HERALD | UPDATED 3 YEARS, 10 MONTHS AGO
Congress, LA take divergent paths after COVID test warning
LOS ANGELES (AP) — Los Angeles will continue using a coronavirus test that federal regulators warned may produce false results while Congress, which has used the same test, is seeking an alternative.
COLUMBIA BASIN HERALD | UPDATED 3 YEARS, 10 MONTHS AGO
Congress, LA take divergent paths after COVID test warning
LOS ANGELES (AP) — Los Angeles will continue using a coronavirus test that federal regulators warned may produce false results while Congress, which has used the same test, is seeking an alternative.
COLUMBIA BASIN HERALD | UPDATED 3 YEARS, 10 MONTHS AGO
LA, Congress take divergent paths after COVID test warning
LOS ANGELES (AP) — Los Angeles will continue using a coronavirus test that federal regulators warned may produce false results while Congress, which has used the same test, is seeking an alternative.
COLUMBIA BASIN HERALD | UPDATED 3 YEARS, 10 MONTHS AGO
US clears Moderna vaccine for COVID-19, 2nd shot in arsenal
WASHINGTON (AP) — The U.S. added a second COVID-19 vaccine to its arsenal Friday, boosting efforts to beat back an outbreak so dire that the nation is regularly recording more than 3,000 deaths a day.
COLUMBIA BASIN HERALD | UPDATED 3 YEARS, 11 MONTHS AGO
US clears Moderna vaccine for COVID-19, 2nd shot in arsenal
WASHINGTON (AP) — The U.S. added a second COVID-19 vaccine to its arsenal Friday, boosting efforts to beat back an outbreak so dire that the nation is regularly recording more than 3,000 deaths a day.
COLUMBIA BASIN HERALD | UPDATED 3 YEARS, 11 MONTHS AGO
US clears Moderna vaccine for COVID-19, 2nd shot in arsenal
WASHINGTON (AP) — The U.S. added a second COVID-19 vaccine to its arsenal Friday, boosting efforts to beat back an outbreak so dire that the nation is regularly recording more than 3,000 deaths a day.
COLUMBIA BASIN HERALD | UPDATED 3 YEARS, 11 MONTHS AGO
US clears Moderna vaccine for COVID-19, 2nd shot in arsenal
WASHINGTON (AP) — The U.S. added a second COVID-19 vaccine to its arsenal Friday, boosting efforts to beat back an outbreak so dire that the nation is regularly recording more than 3,000 deaths a day.
COLUMBIA BASIN HERALD | UPDATED 3 YEARS, 11 MONTHS AGO
US awaits word on 2nd vaccine as COVID-19 outbreak worsens
WASHINGTON (AP) — The U.S. stood on the verge of adding a second COVID-19 vaccine to its arsenal Friday as the outbreak passes through its most lethal phase yet, with the nation regularly recording over 3,000 deaths per day.
COLUMBIA BASIN HERALD | UPDATED 3 YEARS, 11 MONTHS AGO
FDA plans to OK 2nd COVID-19 vaccine after panel endorsement
WASHINGTON (AP) — The head of the Food and Drug Administration said late Thursday that his agency will move to quickly authorize the second COVID-19 vaccine to fight the pandemic, hours after the shot won the key endorsement of a government advisory panel.
COLUMBIA BASIN HERALD | UPDATED 3 YEARS, 11 MONTHS AGO
2nd COVID-19 vaccine set for OK in US with panel endorsement
WASHINGTON (AP) — A government advisory panel endorsed a second COVID-19 vaccine Thursday, paving the way for the shot to be added to the U.S. vaccination campaign.
COLUMBIA BASIN HERALD | UPDATED 3 YEARS, 11 MONTHS AGO
2nd COVID-19 vaccine gets public review ahead of US decision
WASHINGTON (AP) — A second COVID-19 vaccine moved closer to joining the U.S. fight against the pandemic Thursday as government advisers convened for a public review of its safety and effectiveness.
COLUMBIA BASIN HERALD | UPDATED 3 YEARS, 11 MONTHS AGO
Over-the-counter home test for COVID-19 gets US green light
WASHINGTON (AP) — The first home test for COVID-19 that doesn't require a prescription will soon be on U.S. store shelves.
COLUMBIA BASIN HERALD | UPDATED 3 YEARS, 11 MONTHS AGO
US vaccinations ramp up as 2nd COVID-19 shot nears
WASHINGTON (AP) — Hundreds more hospitals around the country began dispensing COVID-19 shots to their workers in a rapid expansion of the U.S. vaccination drive Tuesday, while a second vaccine moved to the cusp of government authorization.
COLUMBIA BASIN HERALD | UPDATED 3 YEARS, 11 MONTHS AGO
Over-the-counter home test for COVID-19 gets US green light
WASHINGTON (AP) — The first home test for COVID-19 that doesn't require a prescription will soon be on U.S. store shelves.
COLUMBIA BASIN HERALD | UPDATED 3 YEARS, 11 MONTHS AGO
FDA allows use of over-the-counter home test for COVID-19
WASHINGTON (AP) — The first home test for COVID-19 that doesn't require a prescription will soon be on U.S. store shelves.
COLUMBIA BASIN HERALD | UPDATED 3 YEARS, 11 MONTHS AGO
US vaccinations ramp up as 2nd COVID-19 shot nears
WASHINGTON (AP) — Hundreds more hospitals around the country began dispensing COVID-19 shots to their workers in a rapid expansion of the U.S. vaccination drive Tuesday, while a second vaccine moved to the cusp of government authorization.
COLUMBIA BASIN HERALD | UPDATED 3 YEARS, 11 MONTHS AGO
US vaccinations ramp up as feds weigh 2nd COVID-19 shot
WASHINGTON (AP) — Hundreds more U.S. hospitals will begin vaccinating their workers Tuesday as federal health officials review a second COVID-19 shot needed to boost the nation’s largest vaccination campaign.
COLUMBIA BASIN HERALD | UPDATED 3 YEARS, 11 MONTHS AGO
US vaccinations ramp up as feds weigh 2nd COVID-19 shot
WASHINGTON (AP) — Hundreds more U.S. hospitals will begin vaccinating their workers Tuesday as federal health officials review a second COVID-19 shot needed to boost the nation’s largest vaccination campaign.
COLUMBIA BASIN HERALD | UPDATED 3 YEARS, 11 MONTHS AGO
White House threatens FDA chief's job over vaccine approval
WASHINGTON (AP) — Hours before the Food and Drug Administration authorized the first COVD-19 vaccine late Friday, a high-ranking White House official told the agency’s chief he could face firing if the vaccine was not cleared by day’s end, two administration officials said.
COLUMBIA BASIN HERALD | UPDATED 3 YEARS, 11 MONTHS AGO
States will start getting COVID-19 vaccine Monday, US says
WASHINGTON (AP) — The nation's first COVID-19 vaccine will begin arriving in states Monday morning, U.S. officials said Saturday, after the government gave the final go-ahead to the shots needed to end an outbreak that has killed nearly 300,000 Americans.
COLUMBIA BASIN HERALD | UPDATED 3 YEARS, 11 MONTHS AGO
White House threatens FDA chief's job over vaccine approval
WASHINGTON (AP) — Hours before the Food and Drug Administration authorized the first COVD-19 vaccine late Friday, a high-ranking White House official told the agency’s chief he could face firing if the vaccine was not cleared by day’s end, two administration officials said.
COLUMBIA BASIN HERALD | UPDATED 3 YEARS, 11 MONTHS AGO
States will start getting COVID-19 vaccine Monday, US says
WASHINGTON (AP) — The nation's first COVID-19 vaccine will begin arriving in states Monday morning, U.S. officials said Saturday, after the government gave the final go-ahead to the shots needed to end an outbreak that has killed nearly 300,000 Americans.
COLUMBIA BASIN HERALD | UPDATED 3 YEARS, 11 MONTHS AGO
Trucks with first COVID-19 vaccine in US get ready to roll
The first trucks carrying a COVID-19 vaccine for widespread use in the United States were set to pull out of a Michigan manufacturing plant Sunday, with the shots that are critical to stopping the nation's coronavirus outbreak destined to reach states a day later.
COLUMBIA BASIN HERALD | UPDATED 3 YEARS, 11 MONTHS AGO
Trucks with first COVID-19 vaccine in US get ready to roll
The first trucks carrying a COVID-19 vaccine for widespread use in the United States were set to pull out of a Michigan manufacturing plant Sunday, with the shots that are critical to stopping the nation's coronavirus outbreak destined to reach states a day later.
COLUMBIA BASIN HERALD | UPDATED 3 YEARS, 11 MONTHS AGO
States will start getting COVID-19 vaccine Monday, US says
WASHINGTON (AP) — The nation's first COVID-19 vaccine will begin arriving in states Monday morning, U.S. officials said Saturday, after the government gave the final go-ahead to the shots needed to end an outbreak that has killed nearly 300,000 Americans.
COLUMBIA BASIN HERALD | UPDATED 3 YEARS, 11 MONTHS AGO
US says COVID-19 vaccine to start arriving in states Monday
WASHINGTON (AP) — The nation's first COVID-19 vaccine will begin arriving in states Monday morning, U.S. officials said Saturday, after the government gave the final go-ahead to the shots needed to end an outbreak that has killed nearly 300,000 Americans.
COLUMBIA BASIN HERALD | UPDATED 3 YEARS, 11 MONTHS AGO
White House threatens FDA chief's job over vaccine approval
WASHINGTON (AP) — Hours before the Food and Drug Administration authorized the first COVD-19 vaccine late Friday, a high-ranking White House official told the agency’s chief he could face firing if the vaccine was not cleared by day’s end, two administration officials said.
COLUMBIA BASIN HERALD | UPDATED 3 YEARS, 11 MONTHS AGO
US allows emergency COVID-19 vaccine in bid to end pandemic
WASHINGTON (AP) — The U.S. gave the final go-ahead Friday to the nation’s first COVID-19 vaccine, marking what could be the beginning of the end of an outbreak that has killed nearly 300,000 Americans.
COLUMBIA BASIN HERALD | UPDATED 3 YEARS, 11 MONTHS AGO
US allows emergency COVID-19 vaccine in bid to end pandemic
WASHINGTON (AP) — The U.S. gave the final go-ahead Friday to the nation’s first COVID-19 vaccine, marking what could be the beginning of the end of an outbreak that has killed nearly 300,000 Americans.
COLUMBIA BASIN HERALD | UPDATED 3 YEARS, 11 MONTHS AGO
White House threatens FDA chief's job over vaccine approval
WASHINGTON (AP) — Hours before the Food and Drug Administration authorized the first COVD-19 vaccine late Friday, a high-ranking White House official told the agency’s chief he could face firing if the vaccine was not cleared by day’s end, two administration officials said.
COLUMBIA BASIN HERALD | UPDATED 3 YEARS, 11 MONTHS AGO
White House threatens Hahn's job over vaccine approval
WASHINGTON (AP) — White House chief of staff Mark Meadows on Friday pressed Food and Drug Administration chief Stephen Hahn to grant an emergency use authorization for Pfizer's coronavirus vaccine by the end of the day or face possible firing, two administration officials said.
COLUMBIA BASIN HERALD | UPDATED 3 YEARS, 11 MONTHS AGO
US panel endorses widespread use of Pfizer COVID-19 vaccine
WASHINGTON (AP) — A U.S. government advisory panel endorsed widespread use of Pfizer’s coronavirus vaccine Thursday, putting the country just one step away from launching an epic vaccination campaign against the outbreak that has killed close to 300,000 Americans.
COLUMBIA BASIN HERALD | UPDATED 3 YEARS, 11 MONTHS AGO
US panel endorses widespread use of Pfizer COVID-19 vaccine
WASHINGTON (AP) — A U.S. government advisory panel endorsed widespread use of Pfizer’s coronavirus vaccine Thursday, putting the country just one step away from launching an epic vaccination campaign against the outbreak that has killed close to 300,000 Americans.
COLUMBIA BASIN HERALD | UPDATED 3 YEARS, 11 MONTHS AGO
US experts convene to decide whether to OK Pfizer vaccine
WASHINGTON (AP) — A U.S. government advisory panel convened on Thursday to decide whether to endorse large-scale use of Pfizer's COVID-19 vaccine to help conquer the outbreak that has killed close to 300,000 Americans.
COLUMBIA BASIN HERALD | UPDATED 3 YEARS, 11 MONTHS AGO
Pfizer COVID-19 vaccine faces last hurdle before US decision
WASHINGTON (AP) — Pfizer's COVID-19 vaccine faces one final hurdle as it races to become the first shot greenlighted in the U.S.: a panel of experts who will scrutinize the company’s data for any red flags.
COLUMBIA BASIN HERALD | UPDATED 3 YEARS, 11 MONTHS AGO
Pfizer COVID-19 vaccine faces last hurdle before US decision
WASHINGTON (AP) — Pfizer's COVID-19 vaccine faces one final hurdle as it races to become the first shot greenlighted in the U.S.: a panel of experts who will scrutinize the company’s data for any red flags.
COLUMBIA BASIN HERALD | UPDATED 3 YEARS, 11 MONTHS AGO
Pfizer vaccine moves closer to getting the OK in the US
WASHINGTON (AP) — U.S. regulators Tuesday released their first scientific evaluation of Pfizer’s COVID-19 vaccine and confirmed it offers strong protection, setting the stage for the government to green light the biggest vaccination effort in the nation’s history.
COLUMBIA BASIN HERALD | UPDATED 3 YEARS, 11 MONTHS AGO
Pfizer vaccine moves closer to getting the OK in the US
WASHINGTON (AP) — U.S. regulators Tuesday released their first scientific evaluation of Pfizer’s COVID-19 vaccine and confirmed it offers strong protection, setting the stage for the government to green light the biggest vaccination effort in the nation’s history.
COLUMBIA BASIN HERALD | UPDATED 3 YEARS, 11 MONTHS AGO
EXPLAINER: Final steps in US review of COVID-19 vaccine
WASHINGTON (AP) — Pfizer’s COVID-19 vaccine is entering the final phase of review before the U.S. government decides whether to allow millions to get the shots.
COLUMBIA BASIN HERALD | UPDATED 3 YEARS, 11 MONTHS AGO
US regulators post positive review of Pfizer vaccine data
WASHINGTON (AP) — Documents released by U.S. regulators Tuesday confirmed that Pfizer's vaccine was strongly protective against COVID-19 and appeared safe -- offering the world’s first detailed look at the evidence behind the shots.
COLUMBIA BASIN HERALD | UPDATED 3 YEARS, 11 MONTHS AGO
Will the US ever have a national COVID-19 testing strategy?
NEW YORK (AP) — As the coronavirus epidemic worsens, U.S. health experts hope Joe Biden's administration will put in place something Donald Trump's has not — a comprehensive national testing strategy.
COLUMBIA BASIN HERALD | UPDATED 3 YEARS, 11 MONTHS AGO
Will the US ever have a national COVID-19 testing strategy?
NEW YORK (AP) — As the coronavirus epidemic worsens, U.S. health experts hope Joe Biden's administration will put in place something Donald Trump's has not — a comprehensive national testing strategy.
COLUMBIA BASIN HERALD | UPDATED 3 YEARS, 11 MONTHS AGO
Pushed to rush, FDA head says feds will get vaccine 'right'
WASHINGTON (AP) — The head of the agency responsible for authorizing COVID-19 vaccines said Tuesday that it would take the time needed to “get this right,” despite increasing pressure from President Donald Trump to speed up the process.
COLUMBIA BASIN HERALD | UPDATED 3 YEARS, 11 MONTHS AGO
FDA chief called to White House as Trump pushes for vaccine
WASHINGTON (AP) — The head of the agency responsible for approving any COVID-19 vaccine for the U.S. was summoned to the White House Tuesday as an increasingly frustrated President Donald Trump complained approval wasn't coming faster.
COLUMBIA BASIN HERALD | UPDATED 3 YEARS, 11 MONTHS AGO
Heading into holidays, US COVID-19 testing strained again
NEW YORK (AP) — With coronavirus cases surging and families hoping to gather safely for Thanksgiving, long lines to get tested have reappeared across the U.S. — a reminder that the nation’s testing system remains unable to keep pace with the virus.
COLUMBIA BASIN HERALD | UPDATED 3 YEARS, 12 MONTHS AGO
FDA allows 1st rapid virus test that gives results at home
WASHINGTON (AP) — U.S. regulators on Tuesday allowed emergency use of the first rapid coronavirus test that can be performed entirely at home and delivers results in 30 minutes.
COLUMBIA BASIN HERALD | UPDATED 3 YEARS, 12 MONTHS AGO
FDA allows 1st rapid virus test that gives results at home
WASHINGTON (AP) — U.S. regulators on Tuesday allowed emergency use of the first rapid coronavirus test that can be performed entirely at home and delivers results in 30 minutes.
COLUMBIA BASIN HERALD | UPDATED 3 YEARS, 12 MONTHS AGO
FDA allows 1st rapid virus test that gives results at home
WASHINGTON (AP) — U.S. regulators on Tuesday allowed emergency use of the first rapid coronavirus test that can be performed entirely at home and delivers results in 30 minutes.
COLUMBIA BASIN HERALD | UPDATED 3 YEARS, 12 MONTHS AGO
US allows 1st emergency use of a COVID-19 antibody drug
WASHINGTON (AP) — U.S. health officials have allowed emergency use of the first antibody drug to help the immune system fight COVID-19, an experimental approach against the virus that has killed more than 238,000 Americans.
COLUMBIA BASIN HERALD | UPDATED 4 YEARS AGO
US allows 1st emergency use of a COVID-19 antibody drug
WASHINGTON (AP) — U.S. health officials have allowed emergency use of the first antibody drug to help the immune system fight COVID-19, an experimental approach against the virus that has killed more than 238,000 Americans.
COLUMBIA BASIN HERALD | UPDATED 4 YEARS AGO
US allows 1st emergency use of a COVID-19 antibody drug
WASHINGTON (AP) — U.S. health officials have allowed emergency use of the first antibody drug to help the immune system fight COVID-19, an experimental approach against the virus that has killed more than 238,000 Americans.
COLUMBIA BASIN HERALD | UPDATED 4 YEARS AGO
FDA panel urges rejection of experimental Alzheimer's drug
WASHINGTON (AP) — Government health advisers sharply criticized a closely watched Alzheimer’s drug on Friday, concluding there wasn’t enough evidence that the experimental drug slowed the brain-destroying disease.
COLUMBIA BASIN HERALD | UPDATED 4 YEARS AGO
FDA panel urges rejection of experimental Alzheimer's drug
WASHINGTON (AP) — Government health advisers sharply criticized a closely watched Alzheimer’s drug on Friday, concluding there wasn’t enough evidence that the experimental drug slowed the brain-destroying disease.
COLUMBIA BASIN HERALD | UPDATED 4 YEARS AGO
FDA panel urges rejection of experimental Alzheimer's drug
WASHINGTON (AP) — Government health advisers sharply criticized a closely watched Alzheimer’s drug on Friday, concluding there wasn’t enough evidence that the experimental drug slowed the brain-destroying disease.
COLUMBIA BASIN HERALD | UPDATED 4 YEARS AGO
FDA panel urges rejection of experimental Alzheimer's drug
WASHINGTON (AP) — Government health advisers sharply criticized a closely watched Alzheimer’s drug on Friday, concluding there wasn’t enough evidence that the experimental drug slowed the brain-destroying disease.
COLUMBIA BASIN HERALD | UPDATED 4 YEARS AGO
FDA panel reviews 1st new Alzheimer's drug in 2 decades
WASHINGTON (AP) — One of the biggest drug decisions in decades is looming as U.S. regulators consider whether to approve the first medicine that's claimed to slow mental decline from Alzheimer's disease, the most common form of dementia.
COLUMBIA BASIN HERALD | UPDATED 4 YEARS AGO
US regulators seek advice on thorny issues as vaccines near
WASHINGTON (AP) — Scientific advisers told U.S. regulators Thursday they’re concerned that allowing emergency use of a COVID-19 vaccine could damage confidence in the shots and make it harder to ever find out how well they really work.
COLUMBIA BASIN HERALD | UPDATED 4 YEARS AGO
US regulators seek advice on thorny issues as vaccines near
WASHINGTON (AP) — Scientific advisers told U.S. regulators Thursday they’re concerned that allowing emergency use of a COVID-19 vaccine could damage confidence in the shots and make it harder to ever find out how well they really work.
COLUMBIA BASIN HERALD | UPDATED 4 YEARS AGO
US regulators, experts take up thorny vaccine study issues
WASHINGTON (AP) — The U.S. regulators who will decide the fate of COVID-19 vaccines took an unusual step Thursday: Asking outside scientists if their standards are high enough.
COLUMBIA BASIN HERALD | UPDATED 4 YEARS AGO
Regulators, experts take up thorny vaccine study issues
WASHINGTON (AP) — The U.S. regulators who will decide the fate of COVID-19 vaccines are taking an unusual step: Asking outside scientists if their standards are high enough.
COLUMBIA BASIN HERALD | UPDATED 4 YEARS AGO
Regulators, experts take up thorny vaccine study issues
WASHINGTON (AP) — The U.S. regulators who will decide the fate of COVID-19 vaccines are taking an unusual step: Asking outside scientists if their standards are high enough.
COLUMBIA BASIN HERALD | UPDATED 4 YEARS AGO
Millions more virus rapid tests, but are results reported?
WASHINGTON (AP) — After struggling to ramp up coronavirus testing, the U.S. can now screen several million people daily, thanks to a growing supply of rapid tests. But the boom comes with a new challenge: keeping track of the results.
COLUMBIA BASIN HERALD | UPDATED 4 YEARS AGO
Millions more virus rapid tests, but are results reported?
WASHINGTON (AP) — After struggling to ramp up coronavirus testing, the U.S. can now screen several million people daily, thanks to a growing supply of rapid tests. But the boom comes with a new challenge: keeping track of the results.
COLUMBIA BASIN HERALD | UPDATED 4 YEARS AGO
Millions more virus rapid tests, but are results reported?
WASHINGTON (AP) — After struggling to ramp up coronavirus testing, the U.S. can now screen several million people daily, thanks to a growing supply of rapid tests. But the boom comes with a new challenge: keeping track of the results.
COLUMBIA BASIN HERALD | UPDATED 4 YEARS AGO
FDA extends pregnancy warning for common pain relievers
WASHINGTON (AP) — Pregnant women should avoid a group of common pain relievers including Advil and Aleve for the last four months of pregnancy, federal health officials said Thursday, expanding the warning from three months.
COLUMBIA BASIN HERALD | UPDATED 4 YEARS, 1 MONTH AGO
AP: Most states fall short of coronavirus testing thresholds
As more states begin to relax their coronavirus lockdowns, most are falling short of the minimum levels of testing suggested by the federal government and recommended by a variety of public health researchers, an Associated Press analysis has found.
COEUR D'ALENE PRESS | UPDATED 4 YEARS, 6 MONTHS AGO
Drugmaker backpedals on specialty status for COVID-19 drug
WASHINGTON (AP) — Facing public criticism, the maker of a promising coronavirus drug said Wednesday it will waive a special regulatory designation that could have allowed it to block competition and boost profits for its treatment.
DAILY INTER-LAKE | UPDATED 4 YEARS, 7 MONTHS AGO
Potential coronavirus treatment granted rare disease status
WASHINGTON (AP) — The pharmaceutical giant that makes a promising coronavirus drug has registered it as a rare disease treatment with U.S. regulators, a status that can potentially be worth millions in tax breaks and competition-free sales.
DAILY INTER-LAKE | UPDATED 4 YEARS, 7 MONTHS AGO
Potential coronavirus treatment granted rare disease status
WASHINGTON (AP) — The pharmaceutical giant that makes a promising coronavirus drug has registered it as a rare disease treatment with U.S. regulators, a status that can potentially be worth millions in tax breaks and competition-free sales.
COEUR D'ALENE PRESS | UPDATED 4 YEARS, 7 MONTHS AGO
Potential coronavirus treatment granted rare disease status
WASHINGTON (AP) — The pharmaceutical giant that makes a promising coronavirus drug has registered it as a rare disease treatment with U.S. regulators, a status that can potentially be worth millions in tax breaks and competition-free sales.
BONNER COUNTY DAILY BEE | UPDATED 4 YEARS, 7 MONTHS AGO
Testing blunders crippled US response as coronavirus spread
WASHINGTON (AP) — A series of missteps at the nation's top public health agency caused a critical shortage of reliable laboratory tests for the coronavirus, hobbling the federal response as the pandemic spread across the country like wildfire, an Associated Press review found.
COEUR D'ALENE PRESS | UPDATED 4 YEARS, 7 MONTHS AGO
Testing blunders crippled US response as coronavirus spread
WASHINGTON (AP) — A series of missteps at the nation's top public health agency caused a critical shortage of reliable laboratory tests for the coronavirus, hobbling the federal response as the pandemic spread across the country like wildfire, an Associated Press review found.
DAILY INTER-LAKE | UPDATED 4 YEARS, 7 MONTHS AGO
Testing blunders crippled US response as coronavirus spread
WASHINGTON — A series of missteps at the nation’s top public health agency caused a critical shortage of reliable laboratory tests for the coronavirus, hobbling the federal response as the pandemic spread across the country like wildfire, an Associated Press review found.
COEUR D'ALENE PRESS | UPDATED 4 YEARS, 7 MONTHS AGO
AP FACT CHECK: Trump's breathless takes on drugs for virus
WASHINGTON (AP) — “Could be a game changer.” “Very exciting.” “The way they acted with this kind of speed is an incredible thing.” “Very powerful.” “This could be a tremendous breakthrough. Tremendous breakthrough.” “We're going to be able to make that drug available almost immediately.” “There's tremendous promise.”
COEUR D'ALENE PRESS | UPDATED 4 YEARS, 8 MONTHS AGO
US virus testing faces new headwind: Lab supply shortages
WASHINGTON (AP) — First, some of the coronavirus tests didn't work. Then there weren't enough to go around. Now, just as the federal government tries to ramp up nationwide screening, laboratory workers are warning of a new roadblock: dire shortages of testing supplies.
DAILY INTER-LAKE | UPDATED 4 YEARS, 8 MONTHS AGO
AP FACT CHECK: Trump falsely claims drug approval for virus
WASHINGTON (AP) — President Donald Trump misstated the facts Thursday when he asserted that the Food and Drug Administration had just approved a decades-old malaria drug to treat patients infected by the coronavirus. After his FDA chief clarified that the drug still needs testing, Trump also overstated the drug's potential …
COEUR D'ALENE PRESS | UPDATED 4 YEARS, 8 MONTHS AGO
US slashes testing rules to speedup coronavirus screening
WASHINGTON (AP) — The Trump administration is slashing regulations governing test development in a bid to ramp up screening for the coronavirus amid nationwide frustration with the slow pace of the effort.
DAILY INTER-LAKE | UPDATED 4 YEARS, 8 MONTHS AGO
Gov't virus testing will prioritize medical staff, elderly
WASHINGTON (AP) — The federal government's effort to rapidly expand testing for the coronavirus will initially focus on screening health care workers and the elderly, Trump administration officials said Sunday.
DAILY INTER-LAKE | UPDATED 4 YEARS, 8 MONTHS AGO
Trump seeks to broaden virus testing; confusion persists
WASHINGTON (AP) — The Trump administration scrambled Friday to broaden testing for the coronavirus with a flurry of new measures, and public confusion persisted over who should be tested and how to get checked for the disease.
DAILY INTER-LAKE | UPDATED 4 YEARS, 8 MONTHS AGO
Trump scrambles to broaden coronavirus testing options
WASHINGTON (AP) — The Trump administration scrambled Friday to broaden testing for the coronavirus with a flurry of new measures, and public confusion persisted over who should be tested and how to get checked for the disease.
COEUR D'ALENE PRESS | UPDATED 4 YEARS, 8 MONTHS AGO
Virus testing is a 'failing,' leaving cases uncounted
NEW YORK (AP) — Seven weeks have passed since the first U.S. case of coronavirus was announced, and the government is failing to account for what could be thousands of additional infections because of ongoing problems with testing.
DAILY INTER-LAKE | UPDATED 4 YEARS, 8 MONTHS AGO
Virus testing is a 'failing,' leaving cases uncounted
NEW YORK (AP) — Seven weeks have passed since the first U.S. case of coronavirus was announced, and the government is failing to account for what could be thousands of additional infections because of ongoing problems with testing.
COEUR D'ALENE PRESS | UPDATED 4 YEARS, 8 MONTHS AGO
As labs ramp up, who can get tested in US for coronavirus?
WASHINGTON (AP) — Can any American who's sick get tested for the worrisome new coronavirus?
DAILY INTER-LAKE | UPDATED 4 YEARS, 8 MONTHS AGO
Juul Labs sought to court state AGs as teen vaping surged
WASHINGTON (AP) — Juul Labs, the nation’s largest electronic-cigarette company, donated tens of thousands of dollars to the campaigns of state attorneys general in an effort to build relationships with these powerful officials and potentially head off legal challenges over how it promoted and sold its vaping products.
DAILY INTER-LAKE | UPDATED 4 YEARS, 8 MONTHS AGO
Juul Labs sought to court AGs as teen vaping surged
WASHINGTON (AP) — It was a blunt warning about the dangers of youth vaping: Georgia Attorney General Chris Carr announced late last month that his state had joined 38 others to investigate whether Juul Labs, the nation’s largest electronic cigarette company, promoted and sold its nicotine-heavy products to teens.
COEUR D'ALENE PRESS | UPDATED 4 YEARS, 8 MONTHS AGO
Juul Labs sought to court AGs as teen vaping surged
WASHINGTON (AP) — It was a blunt warning about the dangers of youth vaping: Georgia Attorney General Chris Carr announced late last month that his state had joined 38 others to investigate whether Juul Labs, the nation’s largest electronic cigarette company, promoted and sold its nicotine-heavy products to teens.
DAILY INTER-LAKE | UPDATED 4 YEARS, 8 MONTHS AGO
US labs await virus-testing kits promised by administration
WASHINGTON (AP) — Trump administration officials doubled down on their promise to deliver 1 million tests for the coronavirus this week as states reported limited testing supplies and federal lawmakers expressed doubts about the government's timeline.
DAILY INTER-LAKE | UPDATED 4 YEARS, 8 MONTHS AGO
US labs await virus-testing kits promised by administration
WASHINGTON (AP) — Trump administration officials doubled down on their promise to deliver 1 million tests for the coronavirus this week as states reported limited testing supplies and federal lawmakers expressed doubts about the government's timeline.
COEUR D'ALENE PRESS | UPDATED 4 YEARS, 8 MONTHS AGO
AP FACT CHECK: Trump's mislaid blame on Obama for virus test
WASHINGTON (AP) — President Donald Trump and his officials are falsely asserting that they’ve accelerated coronavirus testing by easing a restrictive policy introduced by the Obama administration.
COEUR D'ALENE PRESS | UPDATED 4 YEARS, 8 MONTHS AGO
FDA bans shock device used on mentally disabled patients
WASHINGTON (AP) — Federal officials on Wednesday banned electrical shock devices used to discourage aggressive, self-harming behavior in patients with mental disabilities.
BONNER COUNTY DAILY BEE | UPDATED 4 YEARS, 8 MONTHS AGO
FDA bans shock device used on mentally disabled patients
WASHINGTON (AP) — Federal officials on Wednesday banned electrical shock devices used to discourage aggressive, self-harming behavior in patients with mental disabilities.
COEUR D'ALENE PRESS | UPDATED 4 YEARS, 8 MONTHS AGO
FDA bans shock device used on mentally disabled patients
WASHINGTON (AP) — Federal officials on Wednesday banned electrical shock devices used to discourage aggressive, self-harming behavior in patients with mental disabilities.
DAILY INTER-LAKE | UPDATED 4 YEARS, 8 MONTHS AGO
FDA cracks down on illegal diabetes remedies
COEUR D'ALENE PRESS | UPDATED 11 YEARS, 3 MONTHS AGO
Tips for handling your health care needs overseas
COEUR D'ALENE PRESS | UPDATED 11 YEARS, 3 MONTHS AGO
FDA sets new limits on arsenic in apple juice
COEUR D'ALENE PRESS | UPDATED 11 YEARS, 4 MONTHS AGO
Too clean for your own good?
WASHINGTON - It's a chemical that has been in U.S. households for more than 40 years, from the body wash in your bathroom shower to the knives on your kitchen counter to the bedding in your baby's basinet.
COEUR D'ALENE PRESS | UPDATED 11 YEARS, 6 MONTHS AGO
FDA approves first rapid, take home HIV test
WASHINGTON - The Food and Drug Administration has approved the first over-the-counter HIV test, allowing Americans to test themselves for the virus that causes AIDS in the privacy of their homes.
COEUR D'ALENE PRESS | UPDATED 12 YEARS, 4 MONTHS AGO
FDA panel: Revoke drug's breast cancer approval
SILVER SPRING, Md. - A panel of cancer experts has ruled for a second time that Avastin, the best-selling cancer drug in the world, should no longer be used in breast cancer patients, clearing the way for the government to remove its endorsement from the drug.
COEUR D'ALENE PRESS | UPDATED 13 YEARS, 4 MONTHS AGO
New rules to cut confusion on sunscreen claims
WASHINGTON - Help is on the way to consumers confused by the jumble of sun protection numbers and other claims on sunscreens.
COEUR D'ALENE PRESS | UPDATED 13 YEARS, 5 MONTHS AGO
FDA OKs 5-day emergency contraceptive
WASHINGTON - Federal health officials on Friday approved a new type of morning-after contraceptive that works longer than the current leading drug on the market.
COEUR D'ALENE PRESS | UPDATED 14 YEARS, 3 MONTHS AGO
FDA: Diabetes drug should stay on market
WASHINGTON - GlaxoSmithKline's drug Avandia should stay on the market, federal health experts voted Wednesday, but the controversial diabetes pill should be subject to new restrictions due to risky heart side effects.
COEUR D'ALENE PRESS | UPDATED 14 YEARS, 4 MONTHS AGO
FDA review spotlights heart risk of diabetes pill
WASHINGTON - Federal health scientists have panned a GlaxoSmithKline study that the company used to defend the safety of its embattled diabetes drug Avandia, a once blockbuster-seller that has fallen out of favor because of potential ties to heart attacks.
COEUR D'ALENE PRESS | UPDATED 14 YEARS, 4 MONTHS AGO
Prev
Next